Simple Summary Breast cancers that lack expression of the predictive markers oestrogen
receptor, progesterone receptor and human epidermal growth factor receptor-2 are known …

Rare subtypes of triple-negative breast cancers (TNBC) are a heterogenous group of
tumors, comprising 5–10% of all TNBCs. Despite accounting for an absolute number of …

Metaplastic breast cancers (MBC) encompass a group of highly heterogeneous tumors
which share the ability to differentiate into squamous, mesenchymal or neuroectodermal …

Introduction Invasive apocrine carcinoma is a rare breast cancer that is frequently triple
negative. Little is known about the characteristics of its molecular subtypes. We compared …

Metaplastic breast cancer (MpBC) is a rare and aggressive histologic subtype of breast
cancer (BC) characterized by the presence of at least two cellular types, commonly epithelial …

Background Sacituzumab govitecan (SG) is a promising Trop-2-targeted antibody-drug
conjugate (ADC) approved for the treatment of metastatic triple-negative breast cancer …

Adenoid cystic carcinoma (ACC) is a rare malignant epithelial neoplasm that arises in
secretory glands and commonly metastasizes to the lungs. MYBL1 is frequently …

Triple-negative breast cancer (TNBC) is a diverse category with a subset that displays
particularly aggressive characteristics, referred to in this study as “rapid relapse” TNBC …

Consistent standards regarding whether postoperative adjuvant chemotherapy is required in
the treatment of adenoid cystic carcinoma of the breast (ACCB) are currently lacking. Using …

Background Triple-negative breast cancer (TNBC) patients who recur at different times are
associated with distinct biological characteristics and prognoses. Research on rapid-relapse …